155 results
8-K
CHRS
Coherus Biosciences Inc
5 Jun 24
Departure of Directors or Certain Officers
9:11am
an option under the Company’s Amended and Restated 2014 Equity Incentive Award Plan to purchase 168,000 shares of the Company’s common stock with an exercise
8-K
CHRS
Coherus Biosciences Inc
4 Jun 24
Submission of Matters to a Vote of Security Holders
4:05pm
stockholders approved the amendment and restatement of the Company’s 2014 Equity Incentive Award Plan.
BROKER
FOR
AGAINST
ABSTAIN
NON-VOTES
SIGNATURES
DEFA14A
CHRS
Coherus Biosciences Inc
13 May 24
Additional proxy soliciting materials
4:35pm
in the Proxy Statement, in which we ask our stockholders to approve the amendment and restatement of the Company’s 2014 Equity Incentive Award Plan … .
No new awards have been made under the Company’s 2016 Employment Commencement Incentive Plan, or the Inducement Plan, since April 11, 2024, nor
DEFA14A
CHRS
Coherus Biosciences Inc
15 Apr 24
Additional proxy soliciting materials
5:10pm
of the Company’s named executive officers (a “Say-on-Pay” vote). For 4. To approve the amendment and restatement of the Company’s 2014 Equity Incentive Award
S-8
EX-23.2
lhoip djc2ljm1qog
28 Mar 24
Registration of securities for employees
4:04pm
S-8
ngydvtpv2l6 6b9
28 Mar 24
Registration of securities for employees
4:04pm
S-8
EX-5.1
gxfo7jpz
28 Mar 24
Registration of securities for employees
4:04pm
S-8
wzm6758symwte
28 Mar 24
Registration of securities for employees
4:04pm
8-K
cfa4yarc93a
22 Feb 24
Departure of Directors or Certain Officers
4:59pm
8-K
EX-2.1
dyfa8e
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K/A
EX-99.1
4llyq5152evmrf
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
8-K/A
EX-99.2
johjjwuhehde e6mj0i
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
424B5
ijr97
12 Sep 23
Prospectus supplement for primary offering
6:04am